Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

In Vivo Insulin-Mimetic Activity of [N,n′-1,3-propyl-bis(salicyladimine)]oxovanadium(iv)

Synthesis, Crystal Structures and Insulin-Like Activity of Two New Oxidovanadium(v) Complexes with Aroylhydrazones and Maltol Mixed-Ligands

Synthesis, Crystal Structures and Insulin-Like Activity of Three New Oxidovanadium(v) Complexes with Aroylhydrazone Ligand.

A New Orally Active Antidiabetic Vanadyl Complex – Bis(α-Furancarboxylato)oxovanadium(iv)

Synthesis, Structures, and Insulin-Like Activity of Oxidovanadium(v) Complexes Derived from 2-Chloro-n′-(3-ethoxy-2-hydroxybenzylidene)benzohydrazide

Effect of the Chloro-Substitution on Lowering Diabetic Hyperglycemia of Vanadium Complexes with Their Permeability and Cytotoxicity.

Syntheses, Characterization, Crystal Structures and Insulin-Like Activity of Vanadium(V) Complexes with Aroylhydrazone and Maltol Mixed-Ligands

Synthesis, Structures and Insulin-Like Activity of Oxidovanadium(v) Complexes with Aroylhydrazones and Ethylmaltol Mixed-Ligands

Synthesis, Characterization, and Insulin-Enhancing of Vanadium(V) Complexes with Similar Schiff Base Ligands

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Syntheses, Characterization, and Crystal Structures of Two Oxovanadium(V) Complexes with Insulin-like Activity

A New Oxovanadium Complex Enhances Renal Function by Improving Insulin Signaling Pathway in Diabetic Mice.

A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats

4-Fluoro-n’-(2-hydroxy-3-methoxybenzylidene)benzohydrazide and Its Oxidovanadium(v) Complex: Syntheses, Crystal Structures and Insulin-Enhancing Activity

A New Insulin-Enhancing Agent: [N,N '-Bis(4-Hydroxysalicylidene)-O-Phenylene-Diamine]Oxovanadium(Iv) And Its Permeability And Cytotoxicity

Syntheses, Crystal Structures and Insulin Mimetic Activity of Maltolato- and Ethylmaltolato-Coordinated Oxidovanadium(v) Complexes with N′-(3-ethoxy-2-hydroxybenzylidene)-3-methylbenzohydrazide

Synthesis and Characterization of Oxidovanadium Complexes As Enzyme Inhibitors Targeting Dipeptidyl Peptidase IV.

Synthesis And Anti-Diabetic Activity Of New N,N-Dimethylphenylenediamine-Derivatized Nitrilotriacetic Acid Vanadyl Complexes

Syntheses, Structures, Characterizations and Toxicities of Two Vanadium Complexes

Insulin Like Activity and Mechanism of Vanadium Complex